Pricing

Acumen Pharmaceuticals, Inc.

0 followers ·
CHARLOTTESVILLE VA
Acumen Pharmaceuticals is based out of Charlottesville. Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target amyloid-beta oligomers, (A��Os), which Acumen believes to be a key underlying cause of Alzheimer���s disease. The firm last filed a Form D notice of exempt offering of securities on 2013-05-15. The notice included securities offered of Equity

Contact Info

Contact information is taken directly from publicly disclosed SEC filings.

Acumen Pharmaceuticals, Inc.
427 PARK ST.
CHARLOTTESVILLE VA    22902

Business Phone: 925-368-8508
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Recent SEC Filings

Filing Date
S-3 2024-03-27
S-8 2024-03-27
10-K 2024-03-26
8-K 2024-03-26
8-K 2024-03-19
SC 13G/A 2024-02-14
SC 13G 2024-02-06
4 2024-02-01
3 2024-02-01
8-K 2024-02-01